We are live on ! Find out more
HALO icon

Halozyme

210 hedge funds and large institutions have $2.36B invested in Halozyme in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 57 increasing their positions, 85 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

105% more call options, than puts

Call options by funds: $9.37M | Put options by funds: $4.57M

75% more funds holding in top 10

Funds holding in top 10: 47 (+3)

7.76% more ownership

Funds ownership: 87.23%94.99% (+7.8%)

4% more capital invested

Capital invested by funds: $2.27B → $2.36B (+$90.6M)

6% less funds holding

Funds holding: 224210 (-14)

25% less first-time investments, than exits

New positions opened: 33 | Existing positions closed: 44

33% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 85

Holders
210
Holders Change
-14
Holders Change %
-6.25%
% of All Funds
4.62%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.15%
New
33
Increased
57
Reduced
85
Closed
44
Calls
$9.37M
Puts
$4.57M
Net Calls
+$4.8M
Net Calls Change
-$10.4M

HALO Hedge Fund Activity: Q1 2020 in Review

210 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q1 2020, worth a combined $2.36B — up 4% from $2.27B a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of HALO and 33 opened new positions — a net loss of 11 holders — while 85 trimmed existing stakes and 57 added.

The largest buyer was Artisan Partners, adding an estimated $174M. The largest seller was Pictet Asset Management (UK), cutting an estimated $20.6M.

  • 210 institutional investors held Halozyme (HALO) as of Q1 2020, down from 224 in Q4 2019.
  • Funds reported $2.36B of Halozyme stock for Q1 2020, up 4% quarter-over-quarter.
  • 33 funds opened new Halozyme positions in Q1 2020 and 44 closed out, a net change of -11 holders.
  • The largest Halozyme buyer in Q1 2020 was Artisan Partners, an estimated $174M added.
  • The largest Halozyme seller in Q1 2020 was Pictet Asset Management (UK), an estimated $20.6M sold.

Based on aggregated 13F filings for Q1 2020.